Tivic Health Systems

Inactive

TIVC (NCM)

Valion Bio, Inc. is a late-stage immunotherapeutics company based in San Antonio, Texas. Its lead candidate, Entolimod, is a TLR5 agonist in late-stage development for acute radiation syndrome. The pipeline also includes Entolimod for neutropenia and lymphocyte exhaustion, and Entolasta, an optimized Entolimod variant for chronic use. The firm offers CDMO services and was formerly Tivic Health Systems, renamed in April 2026. Incorporated in 2016.